Detalhe da pesquisa
1.
Cost and effectiveness of autologous haematopoietic stem cell transplantation and high-efficacy disease-modifying therapies in relapsing-remitting multiple sclerosis.
Neurol Sci;
2024 Jan 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38277051
2.
A prospective, multicenter study on hematopoietic stem-cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor and 'on-demand' plerixafor in multiple myeloma patients treated with novel agents.
Haematologica;
2023 Nov 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37981892
3.
Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantation.
Eur J Neurol;
30(10): 3362-3366, 2023 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37483174
4.
Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs.
Haematologica;
105(1): 193-200, 2020 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31221778
5.
Autologous stem cell transplantation is safe in selected elderly multiple myeloma patients.
Eur J Haematol;
104(2): 138-144, 2020 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31762088
6.
Long-Term Follow-Up of a Donor versus No-Donor Comparison in Patients with Multiple Myeloma in First Relapse after Failing Autologous Transplantation.
Biol Blood Marrow Transplant;
24(2): 406-409, 2018 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29032267
7.
Toxoplasmosis-Associated Hemophagocytic Lymphohistiocytosis in Allogeneic Transplantation.
J Clin Immunol;
41(4): 843-846, 2021 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33515363
8.
New patterns of relapse in multiple myeloma: a case of "light chain escape" in which FLC predicted relapse earlier than urine and serum immunofixation.
Clin Chem Lab Med;
54(6): 991-5, 2016 Jun 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26581069
9.
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.
Blood;
120(1): 9-19, 2012 Jul 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22498745
10.
Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Clin Infect Dis;
57(6): 794-802, 2013 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23771985
11.
Impact of graft-versus-host disease prophylaxis on outcomes after myeloablative single-unit umbilical cord blood transplantation.
Biol Blood Marrow Transplant;
19(9): 1387-92, 2013 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23850652
12.
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients.
Blood;
117(11): 3025-31, 2011 Mar 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21228328
13.
Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment.
Blood;
118(22): 5759-66, 2011 Nov 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21951682
14.
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study.
Transplant Direct;
9(3): e1451, 2023 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36845852
15.
Allogeneic stem cell transplantation in multiple myeloma relapsed after autograft: a multicenter retrospective study based on donor availability.
Biol Blood Marrow Transplant;
18(4): 617-26, 2012 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21820394
16.
Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: a retrospective survey of 50 patients.
Cancer;
118(6): 1574-84, 2012 Mar 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21932386
17.
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients.
Blood;
116(23): 4745-53, 2010 Dec 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20807892
18.
Late haemophagocytic lymphohistiocytosis in a patient treated with Axicabtagene ciloleucel.
Transpl Immunol;
75: 101719, 2022 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36116729
19.
Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01.
Bone Marrow Transplant;
57(6): 949-958, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35413985
20.
GITMO Registry Study on Allogeneic Transplantation in Patients Aged ≥60 Years from 2000 to 2017: Improvements and Criticisms.
Transplant Cell Ther;
28(2): 96.e1-96.e11, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34818581